First patients enrolled in Cromos Pharma managed Covid-19 trial

First patients enrolled in Cromos Pharma managed Covid-19 trial

Cromos Pharma is proud to be part of the global search for effective COVID-19 treatments. Today we are pleased to announce the enrollment of the first patients in clinical trials designed to be find drugs to treat the symptoms of coronavirus.

“We are honored and humbled to have been enlisted to run clinical trials aimed at finding effective treatments for the symptoms of COVID-19. We are pleased to be able to put our experience and expertise in managing clinical trials to work in the efforts to defeat this pandemic”, says Dr Vlad Bogin, CEO.

Find out more about Cromos Pharma’s efforts in the fight against COVID-19 here.


Cromos Pharma proudly supports the Right2hope initiative, empowering patients to explore treatment options beyond traditional clinical trials. Through an intuitive, AI-supported matching algorithm, Right2hope connects patients with the most relevant expanded access, compassionate use, and right-to-try programs.

Schedule a meeting

We are excited to connect with you, understand your goals, and explore how we can support your needs.

Contact us

OUR PUBLICATIONS